ArticlemAbs

Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis.

Susanne Klint et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.